🇺🇸 FDA
Patent

US 8637503

Phenothiazine enantiomers as agents for the prevention of bone loss

granted A61KA61K31/5415A61P

Quick answer

US patent 8637503 (Phenothiazine enantiomers as agents for the prevention of bone loss) held by The Board of Regents of the University of Texas System expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/5415, A61P, A61P19/10